Back to top

medical: Archive

Zacks Equity Research

Roche Antiviral Drug Reduces Transmission in Late-stage Study

Results from a late-stage study on RHHBY's Xofluza show that the drug reduces the transmission of influenza from an infected person to household members.

RHHBYPositive Net Change PFENegative Net Change LLYNegative Net Change BAYRYNegative Net Change

Zacks Equity Research

Do Options Traders Know Something About Enhabit (EHAB) Stock We Don't?

Investors need to pay close attention to Enhabit (EHAB) stock based on the movements in the options market lately.

EHABPositive Net Change

Zacks Equity Research

New Strong Sell Stocks for September 20th

AMKR, BW and AMFPF have been added to the Zacks Rank #5 (Strong Sell) List on September 20 2024.

AMKRPositive Net Change BWPositive Net Change AMFPFNo Net Change

Zacks Equity Research

Implied Volatility Surging for Tactile Systems (TCMD) Stock Options

Investors need to pay close attention to Tactile Systems (TCMD) stock based on the movements in the options market lately.

TCMDPositive Net Change

Zacks Equity Research

BiomX Stock Gains From Favorable Study Data Presentation on BX004

PHGE is set to present data from its Phase 1b/2a study for BX004 at the North American Cystic Fibrosis Conference in Boston on Sept. 27 and Sept. 28.

AXGNNegative Net Change KIDSNegative Net Change TMDXNegative Net Change PHGEPositive Net Change

Indrajit Bandyopadhyay

4 Stocks to Buy Amid Dental Supplies Industry Challenges

Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include BDX, MCK, COO and STAA.

BDXPositive Net Change MCKNegative Net Change COONegative Net Change STAANegative Net Change

Zacks Equity Research

Innovation Aids Alcon Stock's Growth Despite Macroeconomic Troubles

Banking on strong sales of its contact lenses and ocular health products, ALC is registering solid growth within Vision Care.

BSXPositive Net Change ALCPositive Net Change AXGNNegative Net Change PAHCNegative Net Change

Zacks Equity Research

DGX Stock to Benefit From New Partnership With Sentara Health Plans

Quest Diagnostics extends services in Virginia and Florida via a partnership with Sentara Health Plans.

BSXPositive Net Change DGXPositive Net Change AXGNNegative Net Change PAHCNegative Net Change

Zacks Equity Research

New Strong Buy Stocks for September 20th

QFIN, CLCO, HCA, STRL and CSGS have been added to the Zacks Rank #1 (Strong Buy) List on September 20, 2024.

HCAPositive Net Change CSGSNegative Net Change STRLPositive Net Change QFINPositive Net Change CLCONo Net Change

Zacks Equity Research

Company News for Sep 20, 2024

Companies In The News Are: PGNY, EWTX, FDS, SCS.

FDSPositive Net Change SCSPositive Net Change PGNYPositive Net Change EWTXNegative Net Change

Debasmita Chatterjee

Universal Health Up 23% in 3 Months: Time to Buy or Miss the Boat?

UHS witnesses revenue growth from increased patient volumes and strategic initiatives. An extensive treatment network remains an added strength.

UHSPositive Net Change THCPositive Net Change HCAPositive Net Change

Zacks Equity Research

GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines

Data from a late-stage study shows that co-administering GSK's RSV and Shingles vaccines together was as effective as giving each separately.

GSKPositive Net Change ILMNNegative Net Change KRYSNegative Net Change BVSNegative Net Change

Sundeep Ganoria

Bioventus Surges 103% in Six Months: Is the Stock Worth a Buy?

BVS' stock generates phenomenal returns, driven by double-digit revenue growth across the Pain Treatments and Surgical Solutions franchises.

JNJNegative Net Change MDTPositive Net Change BVSNegative Net Change

Zacks Equity Research

Molina Healthcare Stock Rises 15.4% in 3 Months: Should You Buy?

MOH stock is expected to benefit from contract wins, rising premiums and expansion initiatives.

MOHNegative Net Change LMATPositive Net Change ENSGPositive Net Change AVNSNegative Net Change

Zacks Equity Research

Here's Why You Should Retain McKesson Stock in Your Portfolio Now

MCK's strategic collaborations and strength in Biologics raise optimism about the stock.

DGXPositive Net Change UHSPositive Net Change MCKNegative Net Change ABMNegative Net Change

Zacks Equity Research

GEHC Stock Rises as FDA Clears MIM Software's Centiloid Tool

GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based amyloid imaging.

DGXPositive Net Change UHSPositive Net Change ABMNegative Net Change GEHCPositive Net Change

Zacks Equity Research

EWTX Stock Soars on Upbeat Efficacy Data From Cardiomyopathy Studies

Edgewise stock soars on positive data from an early-stage study and Part A of a mid-stage study of EDG-7500 in obstructive hypertrophic cardiomyopathy patients.

ILMNNegative Net Change KRYSNegative Net Change FULCNegative Net Change EWTXNegative Net Change

Zacks Equity Research

APLT Stock Soars 69% on Positive Update on Galactosemia Drug NDA

Applied Therapeutics stock surges 69% as the FDA says that no advisory committee meeting is required to discuss the govorestat NDA for classic galactosemia.

ILMNNegative Net Change KRYSNegative Net Change APLTNegative Net Change FULCNegative Net Change

Zacks Equity Research

VERO Stock Likely to Get Support From New Regulatory Nod in Australia

The latest approval for Venus Concept in Australia reinforces its position as a global player in the aesthetic technology space.

AXGNNegative Net Change KIDSNegative Net Change TMDXNegative Net Change VERONegative Net Change

Zacks Equity Research

BD Stock Rises as Neopak XtraFlow Syringe Expands in Biologics

BDX launches the Neopak XtraFlow Glass Prefillable Syringe, enhancing drug delivery for biologics and expanding capacity with new high-volume production lines.

BDXPositive Net Change UHSPositive Net Change AVAHNegative Net Change ATIPNegative Net Change

Zacks Equity Research

MMSI Stock Likely to Gain From Cook Medical's Product Portfolio Buyout

Merit Medical expects to solidify its foothold in the underpenetrated global lead management market via the latest asset acquisition.

BSXPositive Net Change BAXPositive Net Change DVANegative Net Change MMSIPositive Net Change

Zacks Equity Research

Abbott Stock Hurt by Macroeconomic Issues & FX Headwind

Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage of its revenues comes from outside the United States.

ABTPositive Net Change AXGNNegative Net Change KIDSNegative Net Change TMDXNegative Net Change

Zacks Equity Research

Select Medical Rises 50.2% YTD: Take Profits or Bet on More Gains?

SEM's profitability is being impacted by rising costs and expenses.

UHSPositive Net Change THCPositive Net Change SEMPositive Net Change CDNANegative Net Change

Zacks Equity Research

QGEN Stock Likely to Gain From Newly Launched Assays for QIAcuity

QIAGEN launches 100 new assays for QIAcuity. The newly launched assays are now available through the company???s GeneGlobe platform.

QGENNegative Net Change AXGNNegative Net Change KIDSNegative Net Change TMDXNegative Net Change

Zacks Equity Research

Here's Why You Should Retain Integer Holdings Stock in Your Portfolio Now

ITGR's research and product development activities raise optimism about the stock. Rising demand for its products bodes well for the company.

BSXPositive Net Change BAXPositive Net Change DVANegative Net Change ITGRNegative Net Change